Free Trial

Albemarle (NYSE:ALB) Earns Hold Rating from Analysts at Truist Financial

Albemarle logo with Basic Materials background

Truist Financial initiated coverage on shares of Albemarle (NYSE:ALB - Free Report) in a research report released on Tuesday morning, MarketBeat Ratings reports. The brokerage issued a hold rating and a $96.00 price target on the specialty chemicals company's stock.

Several other research firms have also issued reports on ALB. Wells Fargo & Company upped their price target on Albemarle from $100.00 to $110.00 and gave the company an "equal weight" rating in a research report on Tuesday, October 8th. Clarkson Capital initiated coverage on shares of Albemarle in a research report on Tuesday, January 14th. They issued a "buy" rating and a $112.00 price target on the stock. Robert W. Baird boosted their price objective on shares of Albemarle from $79.00 to $103.00 and gave the company a "neutral" rating in a research report on Wednesday, December 18th. KeyCorp decreased their target price on Albemarle from $132.00 to $127.00 and set an "overweight" rating for the company in a research note on Tuesday, November 12th. Finally, Oppenheimer dropped their price target on Albemarle from $171.00 to $170.00 and set an "outperform" rating on the stock in a research report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, sixteen have assigned a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Albemarle presently has a consensus rating of "Hold" and a consensus target price of $114.71.

Read Our Latest Analysis on ALB

Albemarle Trading Up 0.5 %

ALB stock traded up $0.45 during midday trading on Tuesday, reaching $86.35. 1,678,502 shares of the company's stock traded hands, compared to its average volume of 2,164,910. Albemarle has a fifty-two week low of $71.97 and a fifty-two week high of $143.19. The business has a 50-day moving average price of $95.69 and a two-hundred day moving average price of $93.44. The company has a market capitalization of $10.15 billion, a P/E ratio of -5.16, a PEG ratio of 3.19 and a beta of 1.58. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.44 and a quick ratio of 1.58.

Insiders Place Their Bets

In other Albemarle news, CEO J Kent Masters sold 2,525 shares of the business's stock in a transaction on Thursday, December 5th. The shares were sold at an average price of $101.12, for a total value of $255,328.00. Following the sale, the chief executive officer now owns 73,747 shares of the company's stock, valued at $7,457,296.64. The trade was a 3.31 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.38% of the company's stock.

Institutional Investors Weigh In On Albemarle

Large investors have recently modified their holdings of the stock. Quarry LP raised its stake in shares of Albemarle by 1,400.0% in the third quarter. Quarry LP now owns 270 shares of the specialty chemicals company's stock valued at $26,000 after acquiring an additional 252 shares during the last quarter. Trust Co. of Vermont raised its position in Albemarle by 606.5% in the 4th quarter. Trust Co. of Vermont now owns 325 shares of the specialty chemicals company's stock valued at $28,000 after purchasing an additional 279 shares during the last quarter. Eastern Bank acquired a new position in Albemarle in the third quarter worth $31,000. Cromwell Holdings LLC grew its holdings in shares of Albemarle by 61.9% during the third quarter. Cromwell Holdings LLC now owns 387 shares of the specialty chemicals company's stock worth $37,000 after purchasing an additional 148 shares during the last quarter. Finally, TD Private Client Wealth LLC lifted its position in Albemarle by 50.4% during the 3rd quarter. TD Private Client Wealth LLC now owns 394 shares of the specialty chemicals company's stock worth $37,000 after buying an additional 132 shares in the last quarter. 92.87% of the stock is currently owned by institutional investors.

About Albemarle

(Get Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Featured Articles

Analyst Recommendations for Albemarle (NYSE:ALB)

Should You Invest $1,000 in Albemarle Right Now?

Before you consider Albemarle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.

While Albemarle currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Transportation Stocks to Watch in 2025: Top Picks for Growth

Transportation Stocks to Watch in 2025: Top Picks for Growth

With President Trump's pro-growth policies fueling demand and improving margins, these stocks are set for potential double-digit growth

Recent Videos

3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash
NVIDIA Stock Under Pressure: DeepSeek and the AI Tech War
Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines